Lazard, Inc. filings document the regulatory record for a financial advisory and asset management company listed on the NYSE under LAZ. Form 8-K reports furnish quarterly and annual results, Regulation FD strategy updates, material agreements, executive officer changes, compensation arrangements, and other material-event disclosures tied to the firm’s advisory and asset management businesses.
Proxy materials cover board elections, governance practices, executive compensation and shareholder voting matters. The company’s risk-factor disclosures address conditions in global and regional financial markets, M&A activity, assets under management, liquidity, third-party exposures and competition, alongside capital-structure and reporting matters.
T. Rowe Price Associates, Inc. amended its Schedule 13G to report beneficial ownership of 9,601,861 shares of Lazard Inc common stock, representing 8.6% of the class. The filing lists 9,547,474 shares as sole voting power. The filing includes the statement that "beneficial ownership is expressly denied."
Ariel Investments, LLC reports beneficial ownership of 5,826,289 shares of Lazard Inc Common Stock, representing 5.2% of the class as of 03/31/2026. The filing states Ariel has sole voting power over 5,265,803 shares and sole dispositive power over 5,826,289 shares. The Schedule 13G notes these holdings are held on behalf of adviser clients; no single client holds an economic interest exceeding 5% of the class. The form is signed by James Prescott, Vice President, Compliance, dated 05/14/2026.
Lazard, Inc. reported stronger results for the three months ended March 31, 2026. Total revenue rose to $779,399 thousand from $669,164 thousand, driven by higher asset management fees and other revenue, while investment banking and advisory fees were roughly stable.
Net income attributable to Lazard increased to $100,916 thousand from $60,375 thousand, with diluted earnings per share rising to $0.91 from $0.56. Results included a $77,990 thousand pre-tax gain from the sale and deconsolidation of the Edgewater management vehicles. Lazard ended the quarter with $1,234,463 thousand in cash, cash equivalents and restricted cash and $1,700,000 thousand of senior notes outstanding. The company repurchased 41,502 shares in the quarter and had $107,295 thousand remaining under its share repurchase authorization.
Lazard, Inc. has entered into a Sale and Purchase Agreement to acquire 100% of Campbell Lutyens Holdings Limited, a global private capital advisory firm focused on fund placement, secondary advisory and GP capital advisory services. The aggregate consideration includes an initial closing payment of $460 million, a deferred payment of $115 million on the second anniversary of closing, and an earn-out of up to $85 million tied to revenue-growth targets through 2030.
The initial consideration is expected to be paid primarily in Lazard common stock using a $46.50 reference price, with cash used for closing adjustments. Deferred and earn-out amounts may be paid in stock, loan notes or cash, subject to a cap that limits total shares issued under the agreement to no more than 19.99% of Lazard’s voting power or outstanding shares at closing, with any excess settled in cash or loan notes. Some stock consideration will be subject to lock-up restrictions over roughly three years, and certain recipients face forfeiture and clawback terms.
The acquisition is subject to regulatory approvals, including conditions related to the U.K. Competition and Markets Authority, and may be terminated if not closed by March 31, 2027; in specified circumstances Lazard would owe a $50 million termination fee. Lazard expects the combined private capital advisory business, branded Lazard CL, to generate about $500 million in 2027 revenue and to be accretive to 2027 earnings and beyond.
Lazard Inc Schedule 13G: Vanguard Portfolio Management reports beneficial ownership of 4,967,500 shares of Lazard Inc. common stock, equal to 5.28% of the class as of 03/31/2026. The filing shows 13,774 shares with sole voting power and reports dispositive power over the full 4,967,500 shares.
Lazard Inc reports an ownership disclosure from Vanguard Capital Management. Vanguard Capital Management states beneficial ownership of 5,807,861 shares of Lazard common stock, representing 6.18% of the class. The filer reports sole voting power over 844,772 shares and sole dispositive power over 5,807,861 shares. The filing is signed by Ashley Grim as Head of Global Fund Administration on 05/01/2026.
Lazard, Inc. reported strong first‑quarter 2026 results with mixed GAAP and adjusted performance. Net revenue rose to $757 million, up 17% from the first quarter of 2025, driven largely by a 42% increase in Asset Management net revenue to $410 million. U.S. GAAP net income grew to $101 million, a 67% increase, or $0.91 per diluted share.
On an adjusted basis, net revenue was $673 million, up 5%, while adjusted net income declined to $47 million, down 23%, with adjusted diluted EPS of $0.42, down 25%. Financial Advisory adjusted net revenue slipped 4% to $356 million, while Asset Management adjusted net revenue rose 17% to $309 million. Assets under management reached $259 billion, up 14% year‑over‑year, supported by $9 billion of net inflows. Lazard also highlighted a definitive agreement to acquire Campbell Lutyens, expected to close in the second half of 2026, and returned $174 million to shareholders in the quarter.
Lazard, Inc. has entered a definitive agreement to acquire Campbell Lutyens Holdings Limited for total consideration of approximately $575 million, payable in part at closing and in part two years later. There is potential additional consideration of up to $85 million based on defined performance criteria over a multi‑year period.
The combined private capital advisory businesses are projected to generate approximately $500 million in estimated 2027 revenue and will form a new global unit, Lazard CL, alongside Lazard’s existing M&A and advisory franchises. Lazard CL will comprise more than 280 advisory professionals across 18 offices, supported by a 60‑person institutional distribution team and a large mandate and transaction track record in fundraising and secondary advisory.
Holcombe Green and Gordon Bajnai are appointed Co‑CEOs of Lazard CL, with Andrew Sealey as non‑executive Chairman. The transaction is expected to be accretive to 2027 earnings and thereafter, with closing anticipated in calendar year 2026, subject to regulatory approvals.
Lazard, Inc. has entered a definitive agreement to acquire Campbell Lutyens Holdings Limited for total consideration of approximately $575 million, payable in part at closing and in part two years later. There is potential additional consideration of up to $85 million based on defined performance criteria over a multi‑year period.
The combined private capital advisory businesses are projected to generate approximately $500 million in estimated 2027 revenue and will form a new global unit, Lazard CL, alongside Lazard’s existing M&A and advisory franchises. Lazard CL will comprise more than 280 advisory professionals across 18 offices, supported by a 60‑person institutional distribution team and a large mandate and transaction track record in fundraising and secondary advisory.
Holcombe Green and Gordon Bajnai are appointed Co‑CEOs of Lazard CL, with Andrew Sealey as non‑executive Chairman. The transaction is expected to be accretive to 2027 earnings and thereafter, with closing anticipated in calendar year 2026, subject to regulatory approvals.
LAZ reporting person Mary A. Betsch disclosed multiple sales of Common stock in March–April 2026. The filing lists a 12,121‑share sale on 03/17/2026 for $496,112.53 and a series of 1,515‑share sales on subsequent dates with listed proceeds.
LAZ filed a Form 144 disclosing an intended sale of 3,030 shares of Common Stock. The notice lists Fidelity Brokerage Services LLC as the broker and a total value of $136,350.00 with an entry date of 04/09/2026. The filing also records a restricted stock vesting of 3,030 shares on 03/16/2026 (compensation) and multiple reported dispositions by Mary A. Betsch in March–April 2026.